Powered by INTIENT, we deliver end-to-end clinical services and technology to our biopharma R&D clients.
The latest in advanced technology and digital capabilities, combined with New Science and innovative approaches to traditional processes, are changing the way the life sciences industry develops new, life-changing treatments for patients.
From advancing the next generation of clinical operating models, to harnessing the digital revolution through data and devices, our team of 750+ professionals – with expertise across strategy, consulting, technology, digital and operations – is supporting our clients as they work to accelerate their clinical development programs. Accenture is helping all of the world’s top ten pharma companies improve or manage operations for their clinical development functions.
Our clinical development capabilities and expertise are helping our biopharma clients transform their businesses.
We can help streamline clinical development with a clear strategy, operating model design, and process optimization – all with effective governance.
We can architect data and technology to enable end-to-end data flow. Services include database setup, data management, training and asset assessment.
We deliver a culture of innovation through our clinical operation solutions. Learn more.
We support a range of technology services through our ecosystem of partners.
INTIENT Clinical helps companies run faster clinical trials with better transparency. Learn more.
INTIENT Clinical helps companies run faster clinical trials with better transparency and easier access to trial information, helping you make smarter strategic decisions.
Built for the industry in collaboration with the Life Sciences Cloud Coalition, INTIENT Clinical is a result of global industry leaders working together to transform R&D and deliver better patient outcomes.
AI could accelerate the ability to reach success or failure and ultimately help bring more targeted, effective drugs and therapies to patients faster.
Digital has the potential to revolutionize clinical trials. Today’s industry challenges require focus on innovation and patient outcomes.